-

Diabetes Reversal Leader Virta Health Showcases Transformative, Long-Lasting Cardiometabolic Health Improvements for Veteran Patients

With virtual treatment, Veterans achieve remarkable success in blood sugar reduction, weight loss, and medication deprescription

SAN FRANCISCO--(BUSINESS WIRE)--Today, Virta Health, the type 2 diabetes reversal leader, announced two-year patient outcomes from its multi-year partnership with the Department of Veterans Affairs (VA). The results, presented at the American Diabetes Association 82nd Scientific Sessions, highlight broad metabolic health improvements for Veteran patients, including long-term blood sugar reduction, clinically-significant weight loss, and medication deprescription.

A whopping 25% of U.S. Veterans suffer from type 2 diabetes, a rate more than double that of the general public. Severe complications from the disease are also common, as diabetes is the leading cause of blindness, end-stage renal disease, and amputation for VA patients. Further, amid the COVID-19 pandemic, higher blood sugar levels and insulin use among Veterans with diabetes were associated with increased risk of hospitalization, admission to the ICU, and death, per research in Diabetes Care.

Preliminary results from Virta’s real-world study of Veterans receiving diabetes reversal treatment show promise for a different trajectory. At two years, patients saw transformative outcomes including:

  • Sustained blood sugar control: More than two-thirds of patients achieved blood sugar levels below the HEDIS measure for diabetes control (HEDIS measures are the most widely used performance benchmark in healthcare).
  • Medication deprescription: Across all diabetes drugs, prescriptions were reduced by one-third.
  • Weight loss: Veteran patients experienced an average weight loss of 7%, exceeding the 5% benchmark for clinically significant weight loss by nearly 50%.
  • Diabetes reversal & remission: One-sixth of patients either reversed their diabetes (A1c <6.5% without diabetes medications excluding metformin) or put the disease into drug-free remission at two years.
  • Broad improvement in cardiometabolic health: HDL cholesterol and triglycerides saw significant improvement.

Further, nearly two-thirds of Veterans remained in treatment at two years—exceedingly high retention as compared to other lifestyle and even pharmaceutical interventions. In contrast, for the National Diabetes Prevention Program, considered the gold standard for lifestyle interventions, only 13% of patients were retained at one year.

Beyond the success of those who remained in treatment, Virta also assessed the progress of Veterans who dropped out. While drop-out is often considered a sign of failure, Virta patients who dropped out saw notable improvements, including clinically-significant weight loss (5.6%) and 50% reduction in prescribed diabetes medications.

For Warren Ridley, a Marine Corps Veteran, the benefits of staying enrolled in Virta’s treatment are clear. While suffering from diabetes for nearly three decades, Warren was prescribed daily insulin injections, among other medications, to control his diabetes complications. Even so, he developed diabetic retinopathy, rendering him legally blind and unable to work, along with Congestive Heart Failure (CHF).

Warren presumed he’d continue suffering from diabetes and its side effects for the rest of his life. Yet, since starting the Virta treatment in August 2019, Warren has reduced his insulin dosage by 96%, lost 63 pounds, restored his kidney health, and no longer has CHF.

"This is a wonderful program,” said Warren. “I actually think it’s one of the best things that has ever happened to me."

Although the pilot is fully enrolled, Veterans interested in participating can indicate interest at www.virtahealth.com/veterans. For information on VA health care, visit www.va.gov/health.

About Virta Health:

Virta Health helps people reverse type 2 diabetes and other chronic conditions. Current approaches manage disease progression through increased medication use and infrequent doctor visits. Virta reverses type 2 diabetes through innovations in technology, nutrition science, and continuous remote care from physicians and behavioral experts. In clinical studies, 94% of patients reduce or eliminate insulin use, and weight-loss exceeds FDA benchmarks by nearly 150%. Virta works with the largest health plans, employers, and government organizations and puts 100% of its fees at risk based on clinical and financial outcomes. To learn more about how Virta is transforming lives by reversing type 2 diabetes and other chronic diseases, visit www.virtahealth.com or follow us on Twitter @virtahealth.

Contacts

Media Contact:
Lauren Cunningham
lauren.volkmann@virtahealth.com
831-331-3307

Virta Health


Release Versions

Contacts

Media Contact:
Lauren Cunningham
lauren.volkmann@virtahealth.com
831-331-3307

Social Media Profiles
More News From Virta Health

New Research Shows Virta Health Cuts Depression by 44% and Anxiety by 30%

DENVER--(BUSINESS WIRE)--New clinical studies from Virta Health, the leader in metabolic disease reversal, show how Virta’s individual nutrition therapy and AI-powered, clinical care can drastically improve the health of adults living with obesity. The research abstracts, presented at ObesityWeek 2026, revealed Virta members showed noticeable improvements across mental health, cognitive function, sleep, physical pain, and workplace productivity, with or without the use of GLP-1s. Today, poor me...

Virta Health Reduces Risk of Heart Attack, Stroke, and Death by 56%

DENVER--(BUSINESS WIRE)--Virta Health, the leader in reversing metabolic disease, today announced new peer-reviewed research published in Cardiology and Therapy which shows members following Virta’s individualized nutrition therapy and AI-powered, continuous clinical care had a 56% lower risk of major cardiovascular events, including heart attack, stroke and death, than those receiving standard care. These results are independent of the use of medications, such as GLP-1s. Cardiovascular disease...

Virta Health Reports 37% Greater Weight Loss When GLP-1s are Paired with its AI-enabled Personalized Nutrition

DENVER--(BUSINESS WIRE)--Virta Health, the leader in metabolic disease reversal, today released its 2026 Reversal Report: Metabolic Care in the GLP-1 Era with a striking finding: Virta members taking GLP-1s achieved substantially better results when medication was paired with the company’s AI-enabled, clinically supervised, personalized nutrition therapy. In a real-world analysis of more than 4,000 adults, those who followed the Virta Method™ achieved 37% greater weight loss after one year than...
Back to Newsroom